StartupTalky

Tag: healthcare

  • Fractal Analytics: Empowering Industries through AI and Analytics

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations.

    Businesses in the financial services sector, known for their strict regulations and cautious nature, are often slow to embrace groundbreaking technologies. However, when they do, it’s a clear sign that a broader shift is happening across industries and regions. This raises a crucial question: how will this acceptance evolve into widespread adoption that delivers real value? The banking and insurance sectors may hold the key, offering valuable lessons for other industries looking to advance their own GenAI strategies.

    Fractal Analytics also examines how one global financial institution is already seeing the benefits—teams are making smarter decisions and boosting productivity thanks to a new tool that automates complex data analysis.

    In this article, we will highlight the various GenAI use cases in financial services. Here’s learning about Fractal Analytics, its Founders, Startup Story, Business Model, Revenue Model, Funding, Acquisitions, Growth, Competitors, and more.

    Fractal Analytics – Company Highlights

    Name Fractal Analytics
    Headquarters Mumbai and New York City
    Sector Artificial Intelligence
    Founded 2000
    Founders Pranay Agrawal and Srikanth Velamakanni
    Website Fractal.ai

    Fractal Analytics – About
    Fractal Analytics – Industry
    Fractal Analytics – Founders
    Fractal Analytics – Startup Story
    Fractal Analytics – Mission and Vision
    Fractal Analytics – Name, Tagline and Logo
    Fractal Analytics – Business Model
    Fractal Analytics – Revenue Model
    Fractal Analytics – Employees
    Fractal Analytics – Challenges Faced
    Fractal Analytics – Funding and Investors
    Fractal Analytics – Mergers & Acquisitions
    Fractal Analytics – Financials
    Fractal Analytics – Advertisements and Social Media Campaigns
    Fractal Analytics – Awards and Achievements
    Fractal Analytics – Competitors
    Fractal Analytics – Future Plans

    Fractal Analytics – About

    Fractal Analytics is a global leader in AI and analytics, helping businesses leverage data to make smarter, more informed decisions. With expertise across multiple industries—ranging from consumer goods and healthcare to insurance, life sciences, retail, and financial services—Fractal is at the forefront of transforming businesses through data.

    Fractal’s approach is grounded in predictive analytics and visual storytelling, enabling companies to not only understand but act on insights for a competitive edge.

    With offices in over 15 countries, including key locations like the United States, United Kingdom, Ukraine, and India, Fractal operates from dual headquarters in Mumbai and New York. The company’s impact and innovation have earned it recognition from industry analysts, including mentions as a “Cool Vendor” and a “Vendor to Watch” by Gartner.

    Fractal continues to push the boundaries of artificial intelligence, delivering tailored solutions that drive growth and operational excellence across sectors.

    Fractal Analytics – Industry

    AI is shaping up to be a game-changer for global development, with experts predicting it could add a staggering $15.7 trillion to the world economy by 2030—more than the combined GDP of India and China today. But what about India’s role in this AI boom? Well, the country is emerging as a powerhouse, boasting the third-largest pool of AI talent globally. Investments in India’s AI capabilities are on the rise, growing at an impressive CAGR of 30.8%, hitting approximately $881 million in 2023 alone.

    What’s fueling this surge? A big part of it is India’s growing semiconductor industry, which is set to become the backbone of AI innovations here. By 2025, India’s AI market could be worth $7.8 billion, with a massive 60% of AI’s contribution to India’s GDP coming from four key sectors: Industrials & Automotive, Healthcare, Retail and Consumer Packaged Goods (CPG). But that’s not all—BFSI (Banking, Financial Services, and Insurance) and Agri-tech are also rapidly emerging as exciting spaces for AI-driven solutions.

    India is gearing up to be a key player in the global AI revolution.

    Fractal Analytics – Founders

    Pranay Agrawal

    Pranay Agrawal - Co-founder and CEO, Fractal Analytics
    Pranay Agrawal – Co-founder and CEO, Fractal Analytics

    Pranay Agrawal serves as the Co-founder and CEO of Fractal, bringing a wealth of expertise in both finance and data science. He is a certified Financial Risk Manager through the Global Association of Risk Professionals and was recognized as one of the Top 20 CEOs of Data Science Service Providers in 2023 by Analytics India Magazine.

    Before joining Fractal, Pranay worked with prominent financial institutions, including ICICI Bank and ANZ Grindlays Bank. His accomplishments have been widely acknowledged, including the prestigious Young Alumni Achiever’s Award from IIM Ahmedabad in 2018-19.

    Pranay holds a Bachelor of Commerce degree from Bangalore University and a postgraduate diploma in management from IIM Ahmedabad. As CEO, his focus is on expanding Fractal’s presence in the U.S. and Europe while developing capabilities that keep pace with the evolving needs of clients.

    “Our goal is to power every human decision within enterprises through analytics, AI and technology. This approach allows us to provide comprehensive support to our clients,” Pranay shared.

    Srikanth Velamakanni

    Srikanth Velamakanni - Co-founder, Group Chief Executive, and Vice-Chairman of Fractal Analytics
    Srikanth Velamakanni – Co-founder, Group Chief Executive, and Vice-Chairman of Fractal Analytics

    Srikanth Velamakanni is the Co-founder, Group Chief Executive, and Vice-Chairman of Fractal Analytics, one of India’s top analytics firms.
    A graduate of IIT Delhi with a degree in engineering and an MBA from IIM Ahmedabad, Velamakanni joined ANZ Investment Bank, where he worked in the structured debt department. Reflecting on his time there, he found the role engaging, working with high-profile clients like Enron and handling sectors such as aircraft finance.

    That’s not all – Mr. Velamakanni is also a Co-founder and Trustee of Plaksha University, which emphasizes core engineering, AI/ML, and mathematics, fostering interdisciplinary learning that blends science with the liberal arts. As part of NASSCOM’s Executive Council, he contributes as a data and AI expert.

    Fractal Analytics – Startup Story

    Fractal Analytics kicked off its journey in 2000 in Mumbai, thanks to the vision of co-founders Srikanth Velamakanni, Pranay Agrawal, Nirmal Palaparthi, Pradeep Suryanarayan and Ramakrishna Reddy. (While Srikanth and Pranay continue to lead Fractal today, the other three co-founders have since moved on.)

    The beginning of a great partnership began when Velamakanni transitioned to ICICI Bank’s structured products group, where he collaborated with Pranay Agarwal, a future co-founder of Fractal, to pioneer India’s first collateralized bond obligation (CBO) in 1999. This is where they saw the potential of using math to improve business outcomes, particularly in banking.

    In 2000, as the internet was booming, it was the perfect time for Fractal Analytics to take shape. The founders seized the opportunity to build algorithms that could track sentiment analysis, capitalizing on the vast amount of data generated by rapidly growing websites. This laid the groundwork for their innovative analytics-as-a-service business, allowing companies to make more informed, data-driven decisions. This insight eventually led to the creation of Fractal Analytics.

    In 2016, Pranay Agrawal stepped up as CEO, succeeding Srikanth Velamakanni, who transitioned to the Group Chief Executive and Executive Vice-Chairman role.

    The company hit a major milestone in January 2022, achieving unicorn status after raising $360 million from private equity firm TPG. This accomplishment has solidified Fractal’s position as a powerhouse in the AI and analytics landscape, poised for even greater success in the future!

    Fractal Analytics – Mission and Vision

    Fractal Analytics is on a mission to leverage AI in ways that make a real difference in the world.

    Vision: Imagine a future where every decision made in businesses is fueled by AI. Fractal believes in this future, where human creativity can flourish, opening doors to exciting new possibilities that can change lives and industries around the globe.

    Mission: Fractal is dedicated to transforming the business landscape by harnessing advanced science and data-driven tools. Their mission is to simplify decision-making, liberating individuals from mundane tasks so they can channel their energy into innovation and creative thinking, driving progress and inspiring new ideas.

    Fractal Logo
    Fractal Logo

    At its core, the logo represents the concept of “fractals,” which are irregular, fractional, and fragmented objects. This design choice reflects the company’s focus on complex systems that are often disordered and multifaceted. Just as fractals can reveal intricate patterns within chaos, Fractal Analytics aims to uncover valuable insights from vast amounts of data, helping businesses navigate the complexities of the modern world.

    This connection between the logo and the company’s mission highlights Fractal’s commitment to transforming disorder into clarity, allowing organizations to harness the potential of their data in a meaningful way.

    Fractal Analytics – Business Model

    Fractal Analytics operates with a robust business model tailored for consumer-facing companies that handle high-volume transactions.

    The company focuses on two primary objectives: 

    • Deeply understanding consumers to enhance engagement & loyalty.
    • improving operational efficiency through data-informed decision-making. 

    Their flagship solution, Customer Genomics, exemplifies this approach by providing a comprehensive view of each customer’s behavior and attitudes. This enables businesses to create personalized marketing strategies that resonate with their target audience. 

    By utilizing proprietary pattern recognition and machine learning algorithms, Fractal learns from every customer interaction, including insights from social media, empowering organizations to act on previously undiscovered patterns in their data. 

    With a specialization in sectors such as consumer goods, financial services, insurance, retail, and technology, Fractal leverages its extensive experience across over 100 countries to deliver 40 productized services designed to enhance customer understanding and drive business success.

    Fractal Analytics – Revenue Model

    Fractal Analytics generates revenue primarily through its subscription-based and project-based analytics services. 

    The company’s diverse offerings encompass artificial intelligence (AI), business intelligence (BI), and customer intelligence (CI), providing clients with a comprehensive analytics toolkit to navigate the complexities of big data. 

    By offering a suite of tailored solutions that integrate scientific decision-making into the operations of their clients, Fractal helps organizations improve business process efficiency and customer experience, ultimately leading to higher market share and profitability.

    Fractal Analytics – Employees

    Fractal Analytics offers a range of benefits designed to enhance employee satisfaction and well-being, scoring an impressive average of 81 out of 100 in perks and benefits. Notable offerings include free food, a flexible work-from-home policy, and a performance bonus. In addition to these, Fractal provides several unique benefits across categories like Health & Wellness and Paid Time Off, fostering a supportive and enriching workplace environment.

    At Fractal, employees, affectionately known as Fractalites, are encouraged to remain curious and continually challenge their capabilities. To support this mindset, the company provides training programs through the Fractal Analytics Academy (FAA). This academy features a comprehensive onboarding program for every new Fractalite, ensuring a smooth transition into the organization. The FAA is committed to ongoing skill and knowledge development, helping employees advance their careers while nurturing a culture where imagination and creativity thrive.

    Fractal Analytics – Challenges Faced

    Fractal Analytics leverages its experience in solving business analytics challenges across industries like consumer packaged goods (CPG), financial services, and retail.

    • Transition from analytics to AI: First, the company had to anticipate client needs years in advance, prompting a significant increase in research and development investment, from 3-4% of revenue to 12.5%. Second, the shift required a change in talent strategy, prioritizing a learning-oriented mindset over specific skills. To address this, Fractal invested heavily in training and development programs, ensuring employees could adapt to evolving AI technologies. Despite these adjustments, the overall transition was relatively smooth, with the core business questions remaining constant.
    • Building a risk model: The lack of sufficient data, posed significant risks, especially in the financial sector where errors could cost banks a fortune. For instance, while developing a personal loan cross-sell model for ICICI’s credit card customers, they encountered thin data for price sensitivity analysis, a relatively new area at the time. To overcome this, Fractal conducted extensive research and wrote a paper on the subject, which they presented to the bank. This built credibility and allowed them to confidently offer their services to other major clients like Citibank and Hindustan Lever.
    • Keeping up with the fast-evolving world of analytics: At Fractal Analytics, the industry changes so quickly that knowledge becomes outdated in just three years. To tackle this, they established the Fractal Academy, a dynamic learning hub designed to keep employees ahead of the curve. By partnering with platforms like eDX and Coursera, Fractal encourages its team to continuously upgrade their skills. Employees can earn credits for completing relevant courses, ensuring they stay sharp and ready to handle the industry’s rapid advancements while maintaining a culture of continuous growth.

    Fractal Analytics – Funding and Investors

    Fractal has raised around $855 million to date including a $360 million round, where the Srikanth Velamakanni and Pranay Agrawal-led company turned unicorn. 

    Date of Funding Funding Amount Round Name Investors
    July 15, 2025 $170 million Secondary share sale
    January 5, 2022 $360 million Series E TPG
    January 17, 2019 $200 million Series D Apax
    May 10, 2016 $100 million Series C Khazanah Nasional Berhad
    August 13, 2014 Undisclosed Series B Aimia
    January 24, 2013 $25 million Series A TA

    Fractal Analytics – Mergers & Acquisitions

    Fractal Analytics has made several acquisitions across three countries, with the majority concentrated in India and the United States. Most of these acquisitions have been focused on AI services and IT services, with two acquisitions in each of these areas. These strategic moves have strengthened Fractal’s capabilities in delivering advanced AI-driven solutions and expanding its footprint in key global markets.

    Acquired On Acquired Company
    January 11, 2022 Neal Analytics
    June 22, 2021 Samya.ai
    January 15, 2021 Zerogons
    January 15, 2021 XStreams
    March 14, 2018 Finalmile Consulting
    June 2017 4i Inc.
    • Fractal Analytics partnered with Final Mile to integrate data science with behavioral science in September 2017.
    • Fractal Announces Merger with Eugenie.ai (June 24, 2024)
    • Fractal Partners with QiCAP.Ai (June 4, 2024)
    • Acquisition of Imagna Analytics (2015)
    • Fractal Analytics has also acquired Mobius Innovations, a Singapore-based startup specializing in mobile-based, context-aware Big Data solutions for an undisclosed sum.

    Fractal Analytics – Financials

    Fractal Financials FY24 FY25
    Operating Revenue INR 2196 crore INR 2765 crore
    Total Expenses INR 2250 crore INR 2575 crore
    Net Loss/Profit INR -55 crore INR 221 crore
    Fractal Financials
    Fractal Financials

    List of 116 Unicorn Startups in India | Top Unicorns in India
    India has already seen 116 unicorn startups. Here’s an exhaustive list of all unicorn companies in India, including those that joined the unicorn club in 2024.
    StartupTalkyAnik Banerjee

    Fractal Analytics – Advertisements and Social Media Campaigns

    Fractal Analytics allocated under $100 million for print advertising over the past year, strategically investing in premium ad units. The company advertised across fewer than 50 different media properties, utilizing a variety of formats to reach its audience. In addition to its advertising efforts, Fractal launched and promoted a new product called MarshallGoldsmith.ai in the last twelve months. MediaRadar, a platform that tracks creative runs on leading websites, magazines, and national television for over 3 million brands, captures Fractal’s advertising presence. Recently, the company has placed several advertisements through its subsidiaries, showcasing its commitment to effective media engagement.

    Fractal Analytics – Awards and Achievements

    Fractal has received the following awards:

    • Best Places to Work in New York 2023
    • Fast 50 Asian American Business: Honored by the US Pan Asian American Chamber of Commerce (USPAACC).
    • Innovation Award: Fractal Analytics received the prestigious Innovation Award at the Direct Marketing Association’s (DMA) annual Analytics Challenge during the DMA2013 Conference & Exhibition held in Chicago.
    • Best in Business for ‘AI and Data’: Best in Business Awards 2023, featured in the Winter issue of Inc. magazine.

    Fractal Analytics – Competitors

    The main competitors of Fractal include:

    • Alteryx
    • Microsoft
    • Qlik
    • ThoughtSpot
    • Altair Engineering
    • AWS
    • BDB
    • Salesforce (Tableau)

    Fractal Analytics – Future Plans

    Fractal prepares for an IPO to raise $400–$500 million at a valuation of around $3 billion. The company has appointed Morgan Stanley, Kotak Securities, and Axis Securities as its IPO bankers and is preparing to file its draft red herring prospectus (DRHP).

    FAQs

    What does Fractal Analytics do?

    Fractal Analytics is an artificial intelligence company offering services across various industries, including consumer packaged goods, insurance, healthcare, life sciences, retail, technology, and finance.

    Who is the CEO of Fractal Analytics?

    Pranay Agrawal is the CEO of Fractal Analytics.

    When was Fractal Analytics founded?

    Fractal Analytics was founded in 2000 by Srikanth Velamakanni, Pranay Agrawal, Nirmal Palaparthi, Pradeep Suryanarayan and Ramakrishna Reddy.

    Who are the competitors of Fractal Analytics?

    The main competitors of Fractal Analytics include Alteryx, Microsoft, Qlik, ThoughtSpot, Altair Engineering, AWS, BDB, Salesforce (Tableau) and others.

  • How Q-Commerce Is Transforming Healthcare: Logistics, Tech, and Local Pharmacy Power

    This article has been contributed by Gaurav Lekhrajani, CEO and Co-founder of Dava Ninja

    Quick commerce, or “q-commerce,” has changed the way we think about delivery beginning as an appealing option for consumers in urban areas to what is now a common business paradigm. However, its use presents special difficulties that extend past speed in highly regulated sectors like healthcare.

    Drawing on his own personal expertise in pioneering healthcare q-commerce platform, explains, “We are not just establishing a more rapid supply chain. In a field where sensitivity and immediacy coexist, seamless, reliable service that recognizes the patient’s needs and the product is the true winner.”

    The Rise of Health-Focused Q-Commerce

    A rising need for domestic health services is driving q-commerce’s entry into the medical sector. Patients want quicker, more reliable delivery for anything from wellness supplies and daily vitamins to urgent prescription drugs for chronic illnesses. Such amenities are particularly needed in urban India, where q-commerce platforms are well-suited to address delivery constraints caused by traffic, mobility, and health facilities. 

    Q-commerce in the healthcare industry is hyper-local, autonomous, and technology-driven, in contrast to typical e-commerce models that depend on centralised warehouses. It makes it possible for local pharmacies to function like online stores, providing customers with immediate access to products in their vicinity.

    Dr. Harshit Jain of Doceree on Healthcare Marketing, Data Privacy, and Work-Life Balance
    In an insightful interaction for International Men’s Day, Dr. Harshit Jain, Founder & Global CEO of Doceree, spoke with StartupTalky about his inspiring journey from physician to healthcare entrepreneur
    StartupTalkyMuskaan Kapoor

    Real-Time Inventory Tech: The Backbone of Speed

    Pharmacy App Features
    Pharmacy App Features

    Live inventory tracking is the first step towards efficient q-commerce supply.   Medication availability, expiration dates, and specific handling guidelines are frequently overlooked by current systems.   Platforms like Dava Ninja guarantee that clients see correct, real-time product listings by implementing user-friendly technology that integrate with pharmacies’ Point-of-Sale (POS) and stock management systems.  

    APIs now include the following new features: 

    • Batch & Expiry Syncing: Prevents order cancellations.
    • Geo-filtered Results: Only items that fall within a specified delivery radius are displayed to customers.
    • AI-driven Stock Forecasting: Assists in restocking medicines according to trends in demand.

    Smart Dispatching Algorithms: Beyond Maps

    The average delivery operator concentrates on optimizing routes. However, healthcare q-commerce needs more intelligent routing. Algorithms must now account for:

    • Medication-specific restrictions (e.g., pill segregation, cold storage).
    • Delivery timing preferences (particularly for senior citizens).
    • Several delivery times for ongoing requirements. 

    Furthermore, depending on unexpected demand, such as during a seasonal flu spike or in areas with a large volume of medication refills, such systems must actively redirect riders to high-priority regions.

    Vocal for Local: Partnering with Local Pharmacies

    Treating each registered drugstore as a micro-warehouse is a significant breakthrough in the healthcare q-commerce principle. Hundreds of small to medium-sized pharmacies are empowered to join a wider online ecosystem thanks to the “vocal for local” strategy. Platforms incorporate these regional suppliers into a tech-first distribution system instead of creating facilities from the ground up. Some advantages are:

    • Reduced delay due to close proximity.
    • Increased level of trust in local brands.
    • Enhanced product storage as a result of controlled pharmacy conditions. 

    Higher order volumes, immediate feedback into consumer patterns, and online payment links are all favourable to pharmacies.

    Tanya Goodwin of Botanical Chemist Palm Cove on Revolutionizing Healthcare
    Tanya Goodwin, founder and CEO of Botanical Chemist Palm Cove, discusses her professional journey, the company’s offerings, challenges, and future plans in this exclusive interview.
    StartupTalkyMuskaan Kapoor

    Subscription and Refill Innovation

    The foundation of patient wellbeing is consistency. Platforms with advanced delivery schedules, prescription reminders, and refill-based subscriptions have a substantial upper hand. For example, Dava Ninja allows users to set up ongoing monthly shipments, combine several household medicines into a single delivery, and get notifications when important prescriptions are about to expire. This increases customer loyalty in addition to improving convenience.

    Enhancing the Customer Experience

    Q-commerce in healthcare requires a user experience that is pleasant and not transactional. Convenience and dependability must be reinforced at all stages, from browsing to delivery confirmation. Important enhancements include:

    These resources foster trust, reduce uncertainty, and personalize the encounter.

    Flexible Fulfilment = Leaner Margins

    This strategy, in contrast to conventional warehouse arrangements, is based on regional execution and market aggregation. It permits:

    • No warehousing expenses: The supply remains in pharmacies.
    • Just-in-time shipping: Minimal chance of expiration.
    • Optimising bundled orders: Combining orders to maximize delivery effectiveness.

    “We’re not competing for profits with enormous capital spends,” Lekhrajani states. ” By building a network of local suppliers with digital intelligence, we are expanding.”

    Hyperlocal Delivery = Smart Unit Economics

    Cost effectiveness is frequently q-commerce’s weak point. However, platforms may reduce per-order expenses by grouping orders, reducing delivery radii, and optimizing routing. Some strategies are:

    • Optional supplements to boost the value of the basket (e.g., vitamins or wellness items). 
    • Suitable delivery fees according to speed.
    • Partnerships with numerous brands of pharmacies to prevent delays and shortages. 

    Additionally, this strategy ensures that users will receive what they require at the appropriate time without putting a strain on their finances.

    Tech-Driven Growth Without Heavy Infra

    This model’s ability to leverage code rather than building for expansion is among its most viable characteristics. Simply enrolling current pharmacies onto the network is the first step in growing into other cities or villages. Short webinars or app-based lessons are frequently used for training. Technology handles the labour-intensive tasks by:

    • Making plug-and-play onboarding possible.
    • Supplying pharmacies with information dashboards to control inventory and sales.
    • Identifying best-selling SKUs and improving performance via data.

    This enables healthcare q-commerce companies to grow rapidly without making significant capital expenditures.

    Healthcare q-commerce is a revolution in the way medical attention is delivered to individuals, not just a continuation of convenience capitalism. Speed is still crucial, but success in this market will be determined by the smooth union of savvy logistics, regional alliances, and sensitive customer experiences.

    As summed up by Gaurav Lekhrajani, “Your local pharmacy will become your medical tech ally in the future, not simply a store. Q-commerce will serve as the bridge.”

    Healthcare Startups With Best Employee Wellness Programs
    Explore startups that enhance workplace well-being, offering solutions for physical, mental, and emotional health support in modern workplaces.
    StartupTalkyGurmeet Walia

  • Tata 1mg Startup Story: An Online Drug Delivery Platform

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations.

    An online pharmacy internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portals. 1mg is a digital consumer healthcare platform, or an online pharmacy center, that makes healthcare accessible, understandable, and affordable.

    1mg was launched in April 2015 after Healthkart separated its generic drug search business, HealthkartPlus, and rebranded it as 1mg. It allows users to find information about medicines prescribed by doctors and also buy it online. Users can find medicines by ailments, class, companies, and brands.

    Let’s go through Tata 1mg’s Startup Story and get a glance at Tata 1mg funding, business model, company profile, turnover, growth, revenue model, founders & more.

    1mg – Company Highlights

    Startup Name Tata 1mg
    Headquarters Gurugram, Haryana, India
    Industry Healthcare
    Founded 2013
    Founders Prashant Tandon, Gaurav Agarwal, Vikas Chauhan
    CEO Prashant Tandon
    Area Served India
    Website www.1mg.com

    About Tata 1mg and How it Works?
    Tata 1mg – Logo and its Meaning
    Tata 1mg – Founder and History
    Tata 1mg – Mission
    Tata 1mg – Business Model
    Tata 1mg – Revenue and Growth
    Tata 1mg – Funding and Investors
    Tata 1mg – Acquisitions
    Tata 1mg – Competitors
    Tata 1mg – Awards and Recognitions
    Tata 1mg – Challenges Faced
    Tata 1mg – Future Plans

    Tata 1mg – About and How it Works?

    Tata 1mg is a developer of an online drug delivery platform intended to make healthcare accessible, understandable, and affordable.

    The company delivers medicines and health products online along with lab test booking, online consultations, and authentic information from healthcare professionals, thereby enabling customers to meet all their healthcare needs in one platform hassle-free.

    1mg.com brings to us, an online platform, which can be assessed for all our health needs. With AI being hailed as the technology of the future, every startup is trying to adapt it in some capacity to streamline and optimize their offerings. Tata 1mg recently started offering a feature, ‘Ask a Doctor,’ which is an intuitive chatbot that asks questions to accurately identify what the problem may be and shows the medicinal specializations under which the ailment may fall. Users can choose from one of them and a doctor, who can diagnose the problem via chat, is assigned to you.

    Tata Digital, a subsidiary of Tata Sons Private Ltd. acquired a major stake in 1mg to further widen the former’s digital offerings on June 10, 2021. Though the amount is still not disclosed by the source, the total valuation of 1mg was $400 million.

    Tata 1mg had the highest number of downloads (184.2K) among telemedicine startups during Jan 1-Feb 10, 2021, as per AppTweak data. It has invested in expanding its cold chain and in contact with vaccine makers for partnerships to participate in COVID-19 vaccination (when the government allows the private sector to get in)

    HealthKart | Company Profile |
    Company Profile is an initiative by StartupTalky to publish verified information
    on different startups and organizations. The content in this post has been
    approved by the organization it is based on. Healthcare is going to fundamentally transform in years to come. Technology
    advancements are at th…
    StartupTalkySarika Anand

    Tata 1mg – Logo and its Meaning

    Tata 1mg is all about medicines and the basic unit for a medicine’s strength is measured in milligrams (mg). And to top it all, 1 MG Road was where the company’s first office was located.

    Tata 1mg Logo
    Tata 1mg Logo

    Tata 1mg – Founder and History

    Gurugram-headquartered e-pharmacy startup Tata 1mg (earlier as HealthKartPlus) was founded by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan in 2013.

    Founders of 1mg - Gaurav Agarwal, Vikas Chauhan, and Prashant Tandon
    Tata 1mg Founders – Gaurav Agarwal, Vikas Chauhan, and Prashant Tandon

    The website was started as HealthKartPlus, a platform for users to have all the information about the medicines. The platform became so popular and got a huge response from the public and users asked the company to start the delivery of the medicines too. Thus, Tata 1mg was started.

    Tata 1mg was launched in April 2015 after Healthkart separated its generic drug search business, HealthkartPlus, and rebranded it as 1mg. The company has three business verticals — Pharmaceuticals, Labs, and Doctors.

    Healthcare Startups With Best Employee Wellness Programs
    Explore startups that enhance workplace well-being, offering solutions for physical, mental, and emotional health support in modern workplaces.
    StartupTalkyGurmeet Walia

    Tata 1mg – Mission

    The company’s mission is to make healthcare accessible, understandable, and affordable for one billion Indians through a comprehensive website and mobile app. Tata 1mg enables consumers to learn more about their medicines in addition to finding more cost-effective substitutes.

    Tata 1mg – Business Model

    Tata 1mg provides services like diagnostics, medicine, preventive healthcare, and online Q&A to its users. Apart from this, they also have native ads on their platforms for pharma companies. In the past year, The company has expanded its pharmacies to 600 cities and also expanded its product range to include homeopathy and Ayurveda range.

    The company used its app to spread information on medicines. They are using push notifications and emails to expand and let people know that they are living in their city. The company also uses offline advertisements depending on the city. They use newspaper advertisements and health camps to spread information. However, a majority of their marketing is digital.

    Tata 1mg makes money with online diagnostics and lab testing services. These account for a majority of their annual revenues. Online medicine delivery, B2B healthcare solutions, and subscription-based care plans form up the rest of their yearly finances.

    Tata 1mg – Revenue and Growth

    Tata 1mg Financials 2023 2024
    Operating Revenue INR 1627 crore INR 1968 crore
    Total Expenses INR 2894 crore INR 2303 crore
    Profit/Loss INR -1255 crore INR -313 crore
    1mg Financials FY24
    Tata 1mg Financials FY24

    In FY24, Tata 1mg’s operating revenue increased by approximately 21%, rising from INR 1627 crore in FY23 to INR 1968 crore. Total expenses decreased by about 20%, dropping from INR 2894 crore to INR 2303 crore. As a result, losses reduced significantly by nearly 75%, improving from INR 1255 crore to INR 313 crore.

    EBITDA

    FY23 FY24
    EBITDA Margin -71.66% -10.85%
    Expense/₹ of Op Revenue ₹1.78 ₹1.17
    ROCE -341.99 NA

    Tata 1mg saw strong and steady growth in FY23 without spending too much cash. FY23 was also its first full year under Tata Digital.

    1mg’s operating revenue jumped 2.5 times to INR 1,627 crore in FY23, up from INR 627 crore in FY22, as per its financial reports. Earlier, in FY22, the company had nearly doubled its revenue from INR 309 crore in FY21.

    As per regulatory filings, Tata 1mg’s total revenue was INR 369.3 crore in FY20, which is over a 77% jump from the company’s revenue which stood at INR 209.1 crore in FY19.

    Selling medicines online hasn’t been all easy as this space witnessed regulatory challenges back in 2019. While the Delhi High Court had ordered all state governments to ban the online sale of medicines in January last year, the central drug regulator had asked states to enforce a court directive prohibiting online medicine sales this month.

    Amidst this regulatory uncertainty, Gurugram-based Tata 1mg has demonstrated decent growth with a 2.8X jump in operating revenue. Registering 180% growth, it has posted a total operating revenue of INR 240.85 crore.

    The company collected Rs 39.45 crore from offering marketplace services and INR 68.3 crore through online diagnostics and lab testing services in the year ending March 2019. It also made INR 67.8 lakhs from collection charges.

    Importantly, the overall revenue from services grew 90.2% from INR 41.8 crores in FY18 to INR 79.5 crores in FY19. All services together accounted for a little over one-third of the total revenues generated by Tata 1mg during last fiscal in 2019.

    ImpactGuru – Business Model, Funding, Founders, Careers, wiki
    Would you have been able to imagine a crowdfunding startup to be able to meet
    all your healthcare need? This is where ImpactGuru comes in. In a survey carried
    out by NSO in July 2017-June 2018, it was found that only 14% of the rural
    population and 19% of the urban population had health expenditure …
    StartupTalkyShubham Kumar

    Tata 1mg – Funding and Investors

    Tata 1mg has raised a total of $230.8 million in funding over 16 rounds. Their latest funding was raised on Sep 6, 2022 from a Corporate Round led by Tata Digital. This funding round made Tata 1mg a unicorn as the company was valued $1.25 and $1.30 billion after raising $40 million in funding. Tata 1mg is funded by 10 lead investors. Tata Digital is the most recent investor.

    Tata 1mg funding details are as follows –

    Date Round Amount Lead Investors
    September 6, 2022 Corporate Round $40M Tata Digital
    April 19, 2021 Debt Financing $13.3M Tata Group
    Jul 3, 2020 Debt Financing $17.8M –
    Jan 31, 2020 Venture Round $9.48M Bill & Melinda Gates Foundation
    Jun 28, 2019 Series D $70M Corisol Holding AG, International Finance Corporation
    Apr 5, 2019 Series D $10.3M Redwood Global Healthcare Fund
    Jan 1, 2019 Venture Round – InnoVen Capital
    Mar 1, 2018 Series C $10.1M Maverick Ventures
    Jul 26, 2017 Series C $15M HBM Healthcare Investments AG
    Jul 1, 2017 Series C $12.2M –
    Jun 30, 2017 Venture Round $10M HBM Healthcare Investments AG, Sequoia Capital India
    May 31, 2016 Venture Round – HBM Healthcare Investments AG
    April, 2021 Debt Financing $13.35M Tata Digital

    Tata 1mg – Acquisitions

    Tata 1mg has acquired 3 organizations. Their most recent acquisition was Dawailelo on Sep 1, 2017.

    Acquiree Name Date Amount About Acquiree
    Dawailelo Sep 1, 2017 – Dawailelo is a Varanasi-based healthcare startup that helps people connect with medical stores
    MediAngels Dec 14, 2016 – MediAngels delivers healthcare globally
    Medd.in July 5, 2016 – Medd.in is an online platform to book diagnostic and imaging tests

    Tata 1mg – Competitors

    Tata 1mg’s top competitors are Netmeds, Practo, Medlife, PharmEasy, Metarain Distributors Private Limited, HealthKart, CareOnGo, mChemist and BookMEDS.

    PharmEasy Success Story | Business Model | Revenue | Founders | Funding
    Company Profile is an initiative by StartupTalky to publish verified information
    on different startups and organizations. The content in this post has been
    approved by the organization it is based on. PharmEasy has developed a health care delivery platform to simplify and
    modernize the health care …
    StartupTalkyPurbalee Dutta

    Tata 1mg – Awards and Recognitions

    In 2014, just a year after they started off, Tata 1mg won the m-billionth award for m-health in South Asia. They were also recognized as the most promising healthcare startup by News Corp VCCircle. In 2016, Tata 1mg was acknowledged as the Best App in the medical category by Gmasa.

    They also won the award for the best online pharmacy in India at the International Quality Awards. They achieved the title ‘New Kid on the Block’ at the NDTV Unicorn Awards in the same year.

    Tata 1mg was recognized as one of the Top 50 ventures in the Smart CEO-Startup50 India 2017 program. By the year 2017, the company had grown by 600% in terms of the success of the Tata 1mg app and user engagement. They expanded their product range to encompass Ayurvedic medicines and homeopathy.

    Within the years 2016 and 2017, the company had raised 37 million dollars through 5 rounds of funding. In 2018, Tata 1mg won the BML Munjal Award for ‘Business Excellence through Learning and Development’. During the Content Leadership Awards in 2018, they won the title ‘Best Content in a Healthcare/Fitness App’. Tata 1mg was also recognized as the ‘Best Mobile Innovation for Health award ‘ at the India Mobile Congress.

    Practo’s Business model, Explained
    Practo is an Indian based company that is now established in about 15 countries.
    It is an application that works as a bridge between doctors and patients and is
    mainly focused on booking interactions with doctors. It was founded by 2 Indian
    B.Tech students, Shashank ND and Abhinav Lal. They aimed to…
    StartupTalkySandhya Raju

    Tata 1mg – Challenges Faced

    1mg was initially started as HealthKartPlus, a platform that aggregated medical information and sold alternative medicine to its users. The platform caught up quickly with the users and soon the users began asking for delivery of medicines to be included as well. At a time when information and awareness about medicines and lab tests were either minimal or non-existent, 1mg aimed to change it.

    Tata 1mg has a system in place where they onboard vendors onto the platform if they meet certain requirements like computerized inventory and invoicing, which makes end-to-end tracking easier for the customer. The startup can generate business even after strict government compliances which banned online pharmacies by making a prescription mandatory to make a purchase.

    Tata 1mg – Future Plans

    Aggressively moving towards its expansion plans, Tata 1mg has decided to expand the scope of its platform and is entering the alternate medicine space (AYUSH categories) through the acquisition of Homeobuy.com. Homeobuy is a web platform for homeopathy medicines.

    With this acquisition, Tata 1mg will re-brand the website to www.1mgAyush.com and make homeopathic & ayurvedic medicines available to customers in New Delhi. The Indian government has also been actively supporting and developing the AYUSH categories, as a strong system of medicine that has evolved over a long period of time.

    After Tata Digital’s acquisition of the majority stakes in Tata 1mg, the company announced that they are looking forward to promising 60-minute deliveries in selected locations around the country. Tata 1mg is known for 4-5 hour deliveries in a bunch of locations, which will also be extended to other locations as well.

    “We are the platform that stands for consumer health and we believe the alternate forms of medicines are equally important. Having seen the importance of these alternative forms of medicines and our government’s support in promoting them, we aim at creating an exhaustive platform for all health solutions. The business will continue to work on a marketplace network model and partner with quality vendors in this sector,” said Prashant Tandon.

    FAQs

    What is 1mg?

    1mg is a digital consumer healthcare platform that makes healthcare accessible, understandable, and affordable. It allows users to find information about medicines prescribed by doctors and also buy them. Users can find drugs by ailments, class, companies, and brands.

    Who is Tata 1mg founder?

    Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan are the founders of 1 mg company.

    Who is the CEO of 1mg?

    Prashant Tandon is the CEO & Co-Founder at 1mg.

    How does 1mg make money?

    1mg makes money with online diagnostics and lab testing services. These account for a majority of their annual revenues. Online medicine delivery, B2B healthcare solutions, and subscription-based care plans form up the rest of their yearly finances.

    Is 1mg an Indian company?

    Yes, 1mg is India’s leading consumer health platform.

    How do you order medication 1mg?

    You can send the list of medicines, your full address, contact number, and valid prescription to order@1mg.com.

    Does Tata 1mg provides franchise opportunity?

    Tata 1mg provides a franchise model, enabling individuals to partner with the brand and open their own 1mg store.

  • PB Fintech will Establish a Fully-Owned Subsidiary for Healthcare Services

    The board has given PB Fintech, an insurtech major, permission to establish a new subsidiary in order to provide healthcare services. “The incorporation of the wholly owned subsidiary has been approved by the board of directors of PB Fintech Limited through a circular resolution passed on December 03, 2024, to carry on the business of healthcare services,” the insurtech major stated in a filing with the BSE.

    PB Fintech added that the incorporation procedure would be finished after receiving approval from the appropriate authorities and that it will submit an application to float the new healthcare-focused company at a later time. At a face value of INR 10 each, the listed insurtech platform and other corporate nominees will initially purchase 50,000 equity shares of the new firm.

    The Subsidiary will be Launched With the Approx. Investment of $100 Mn

    Two months ago, Yashish Dahiya, the group CEO and chairman of PB Fintech, stated that the company is thinking about entering the healthcare industry and would invest $100 million one time to purchase a 30% share in a new healthcare startup. He brought up concerns at the time about middle-class families’ inability to afford the nation’s healthcare system.

    According to him, PB Fintech would try to close the gap that exists between insurance firms and hospitals. The announcement, however, caused a significant reaction from the markets. Following Dahiya’s suggestion at the company’s latest experiment, the shares fell as much as 10% during intraday trading on September 26. However, after he formally acknowledged the situation to the media on September 30, shares experienced a significant recovery.

    The New Subsidiary will Focus on Health Care and Allied Services

    The subsidiary, which has an INR 5 lakh authorised share capital, will concentrate on healthcare and related services. The business made it clear that upon incorporation, the new entity will become a connected party. Since PB Fintech is a professionally run company, it does not have a single promoter or promoter group.

    After receiving the required approvals from the Registrar of Companies and the Ministry of Corporate Affairs, the incorporation procedure will start. The transaction signifies PB Fintech’s strategic expansion into the healthcare industry, even though turnover statistics are not yet available due to the entity’s unestablished status.

    Financial Dynamics of PB Fintech

    The healthcare plans offered by PB Fintech had previously drawn criticism from broking firm Bernstein, which stated that the move would represent a “sharp departure from the company’s current asset-light model to a more asset-heavy space.” In terms of finances, PB Fintech keeps increasing its earnings. In the second quarter (Q2) of the fiscal year 2024–25 (FY25), the company reported a net profit of INR 51 Cr, compared to a net loss of INR 21.11 Cr in the same period last year. From INR 811.6 Cr in Q2 FY24 to INR 1,167.2 Cr in the reviewed quarter, revenue from operations increased by more than 43%.

    Paisabazaar Gets IT Department Notices Over Vendor Payments
    Paisabazaar receives notices from the IT Department concerning vendor payments, prompting scrutiny over potential irregularities in financial transactions.
    StartupTalkyNitin Konde

  • Davinder Bhasin on Creating One Health Assist, Revolutionising Healthcare, and Prioritising Mental Health in Leadership

    On this International Men’s Day, StartupTalky connected with Davinder Bhasin, Founder of One Health Assist, a platform transforming health management through digital solutions. Bhasin explains how his personal challenges with the healthcare system led him to create One Health Assist. He talks about how technologies like AI and machine learning help offer personalised health insights and makes healthcare more accessible. Bhasin also shares advice on maintaining work-life balance and why men in leadership should prioritise their mental health. His journey shows how One Health Assist is shaping the future of healthcare.

    StartupTalky: What inspired the creation of One Health Assist, and how did your experience across different industries shape this vision? 

    Mr. Bhasin: One Health Assist was born out of the challenges faced by us when dealing with the healthcare system. When my mother was diagnosed with a serious condition, I had to travel between cities for her treatment. Being mindful of every document was difficult amidst the rush. The constant worry is a heavy burden because misplacing a document can have consequences. One Health Assist’s journey began when Karan (co-founder of One Health Assist) and I discussed our ordeals. Given that he has also faced similar circumstances, realizing the commonality of this problem was quick.

    We set out with a vision to build a holistic health and wellness care ecosystem. Our professional and personal experiences highlighted to us, not only how big the challenge was, but also how big the opportunity was. My diverse experience across industries highlighted a consistent gap: the need for integrated, user-centric solutions. In every sector, data serves as the backbone for informed decisions, but in healthcare, it’s even more critical – as my personal experience exhibited. Thus, keeping data central, we designed the interface with a vision that eventually the platform will evolve into the go-to support system for individuals to follow a wellness-oriented lifestyle.

    StartupTalky: One Health Assist is aiming to become the largest health data repository. What key strategies are you using to scale and expand this platform? 

    Mr. Bhasin: To scale and expand One Health Assist, we’re focusing on strengthening our health repository. It is a free & user-friendly feature, that serves as the backbone of our ecosystem, that can be a transformative support system across the wellness journey. This platform is designed to digitize and centralize medical records, addressing the challenges of managing physical documents—especially for those traveling for treatment, whether within a city or internationally.

    Handling physical health records can be cumbersome and time-consuming, and the risk of damage to the documents or outright misplacement is ever-present. By offering a digital solution such as storage, viewing and sharing all health records like angiography, X Ray etc. we eliminate these risks, ensuring critical information is secure, easily accessible, and protected from damage. 

    However, our health repository is more than just a digital storage solution—it’s about changing the way individuals engage with their healthcare. We are moving beyond basic record-keeping to include advanced features like health scoring and personalized treatment plans, which provide actionable insights tailored to individual needs. Our commitment is to make healthcare management not only more convenient but also genuinely transformative, empowering users with timely and accurate insights to improve their wellness journey.

    StartupTalky: How does One Health Assist differentiate itself from other digital health platforms in terms of technology and user experience? 

    Mr. Bhasin: One Health Assist stands out by offering a comprehensive health-tech ecosystem, with our health repository serving as the platform’s dynamic core. We leverage advanced algorithms to transform stored data into personalized insights, including the One Health Score, which gives users a comprehensive view of their well-being. This score is a proactive tool, that helps individuals manage health risks with expert-driven recommendations.

    Privacy and data security are our top priorities. Our platform is HIPAA-compliant, featuring end-to-end encryption to safeguard user information. Partnerships with AWS and TTML further enhance our data security, ensuring a reliable and private environment for accessing health records and diagnostics.

    Additionally, we are one of the few platforms to integrate pet care, offering telemedicine services that connect users to licensed veterinarians. This holistic approach makes healthcare not only accessible but also secure, personalized, and family-inclusive.

    StartupTalky: What role do emerging technologies like AI and machine learning play in the development of One Health Assist’s services? 

    Mr. Bhasin: Emerging technologies like AI and machine learning are the cornerstone of our vision at One Health Assist. These technologies allow us to offer a seamless and personalized wellness journey by analyzing vast amounts of data to generate predictive insights.

    For example, AI helps us provide tailored lifestyle recommendations based on individual health records, enabling proactive management of chronic conditions. Machine learning also drives our predictive models, which can anticipate potential health risks, providing users and their healthcare providers with critical early warnings. 

    This is why AI is embedded across our ecosystem to ensure that health insights are not only accurate but also easy to understand and act upon. By harnessing these technologies, we aim to enhance the accessibility and quality of care, transforming health management into a continuous, data-driven experience.

    Revolutionizing Patient Communication and Engagement with AI in Healthcare
    Explore how AI-powered tools are reshaping patient-provider interactions, enhancing adherence to treatment plans, and revolutionizing healthcare delivery.
    StartupTalkySubham Kumar

    StartupTalky: How does One Health Assist simplify health management and make critical health data more accessible for users?  

    Mr. Bhasin: One Health Assist simplifies health management by offering a single, centralized platform for all medical information. By digitizing health records, we address the common issues associated with physical documents—storage space, degradation over time, and accessibility during travel. Our platform ensures that vital information is always within reach, whether you’re consulting a local doctor or seeking specialized treatment abroad.

    Additionally, our technology includes features like personalized health scoring and tailored recommendations, which transform static data into actionable insights, guiding users toward better health outcomes. 

    These digital storage solutions is free for everyone and we hope that we are able to serve the masses and hopefully ease the pain.

    StartupTalky: What corporate wellness solutions does One Health Assist offer to enhance employee health and productivity? 

    Mr. Bhasin: At One Health Assist, we believe that healthy employees are the foundation of a thriving business.

    Our corporate wellness packages are crafted to prioritize proactive employee well-being, going beyond traditional mediclaim policies.

    Our Preventive Health Care Package focuses on sustaining good health rather than merely addressing illness.

    Through comprehensive health screenings, lifestyle assessments, mental health support, fitness programs, and personalized wellness workshops, we empower employees to lead healthier, happier, and more productive lives.

    By investing in prevention, an organization can reduce absenteeism, enhance employee engagement, and cultivate a culture of wellness.

    StartupTalky: On International Men’s Day, how do you manage work-life balance and what advice would you give to men in leadership roles to protect their mental health? 

    Mr. Bhasin: People are often subjected to some unique challenges, especially in leadership roles, where societal expectations often place undue pressure on their mental and physical health. The perception that men should be stoic and unaffected by stress can lead to a reluctance in seeking help, contributing to higher rates of mental health issues like anxiety and depression, which are often underreported.

    This is why balancing work and personal life is a continuous effort, and it requires conscious prioritization. For me, managing work-life balance involves setting boundaries, making time for family, and dedicating moments to recharge. My advice to men in leadership roles is to make mental health a priority—just as we prioritize strategic decisions in business, we should also plan for self-care and mindfulness. It’s important to normalize conversations around mental well-being and seek professional guidance if needed. 

    Effective leaders understand that taking care of their mental health not only improves their decision-making but also sets a positive example for their teams. Encourage open dialogue, be transparent about the challenges, and ensure you’re taking steps to stay well-rounded and resilient in every aspect of life.

    Dr. Harshit Jain of Doceree on Healthcare Marketing, Data Privacy, and Work-Life Balance
    In an insightful interaction for International Men’s Day, Dr. Harshit Jain, Founder & Global CEO of Doceree, spoke with StartupTalky about his inspiring journey from physician to healthcare entrepreneur
    StartupTalkyMuskaan Kapoor

  • Dr. Harshit Jain of Doceree Discusses Healthcare Marketing Innovation, Data Privacy Challenges, and Work-Life Balance

    In an insightful interaction for International Men’s Day, Dr. Harshit Jain, Founder and Global CEO of Doceree, speaks with StartupTalky about his inspiring journey from physician to healthcare entrepreneur. Dr. Jain shares how his medical background inspired the creation of Doceree and influenced his approach to healthcare marketing, focusing on the importance of relevant, data-driven solutions for healthcare professionals.

    He discusses the challenges of scaling the business, such as addressing data privacy issues and improving ad relevance. Dr. Jain also touched on the importance of work-life balance and mental health, urging men in demanding roles to prioritise self-care and open discussions about their well-being.

    StartupTalky: What inspired you to transition from being a physician to a healthcare entrepreneur?

    Dr. Jain: Growing up, I vaguely remember my parents talking about my curiosity and knack for coming up with ideas to collaborate with others and help them. As I matured, I thought, what better way to channel that passion than by becoming a doctor? After earning my medical degree from Northwestern University in Chicago in 2006, I practiced medicine for over eight years as a physician.

    During this time, I began noticing unaddressed gaps in the healthcare industry—issues that required creative problem-solving. This inspired me to step beyond the traditional boundaries of a physician’s role and explore the ‘creative’ side of the healthcare industry.

    Despite scepticism from some industry peers, I trusted my instincts and pursued my transition into healthcare advertising, eventually giving me opportunities to hold leadership roles at McCann Health across Asia, Europe, and the United States. Along the way, I thankfully earned some of the industry’s most prestigious awards, including the Cannes Lions Grand Prix for Good, for my marketing campaigns.

    However, my journey didn’t end there. My instincts pushed me further, inspiring me to combine my expertise in medicine and marketing through entrepreneurship, leading to the launch of Doceree in 2020. This transition to entrepreneurship was driven by my aspiration to reduce the rising healthcare costs and improve HCP-patient engagement.

    StartupTalky: How did your medical background influence the creation of Doceree’s ‘smart nudges’ in healthcare marketing?

    Dr. Jain: As a practicing physician for over eight years, I witnessed firsthand the frustration caused by irrelevant advertisements, which disrupt care delivery and doctor-patient engagement, ultimately impacting overall health outcomes. However, my subsequent transition into marketing and entrepreneurship inspired me to turn this challenge into an opportunity to ‘smartly nudge’ the concept of ‘purposeful ads’ in global healthcare advertising.

    By delivering only relevant ads tailored to doctors’ medical backgrounds and patient data—within strict regulatory compliance— we are able to minimize distractions for HCPs and parallelly also help marketers achieve higher returns on advertising spend (ROAS). This move ultimately helped us address two critical issues of the industry: reducing rising healthcare costs and alleviating the mental clutter in a field where life-altering decisions are made daily.

    StartupTalky: What were your biggest challenges in scaling Doceree, and how did you overcome them?

    Dr. Jain: Given that the global healthcare industry is the world’s third-largest producer of data, there were not many solutions capable of systematically harnessing these datasets to make them more marketing and healthcare business-friendly. This is the gap where Doceree sought to differentiate itself by developing data solutions that are not only optimized for marketing but also capable of tracking business outcomes for pharmaceutical marketers.

    As a result, we became the world’s first and only programmatic marketing network exclusively for HCP-only platforms, enabling marketers to directly target the key decision-makers impacting their business outcomes, eliminating unnecessary marketing expenses.

    Once we overcame this challenge, the next hurdle was addressing data privacy concerns. With the rise in data breaches and cases of data misuse, the industry grew increasingly sceptical about digital solutions. To address this, we leveraged our extensive HCP and patient data responsibly, utilizing only the datasets that were relevant and precise for specific moments of care for HCPs. This approach enabled our technology to achieve certification under the Health Insurance Portability and Accountability Act (HIPAA) and secure a patent from the United States Patent and Trademark Office (USPTO), earning the trust of key stakeholders in the process.

    After addressing privacy concerns, the next and perhaps the most significant challenge was tackling inefficient messaging to HCPs. With many solution providers capitalizing on the limited awareness of programmatic marketing in healthcare and claiming to be ‘experts’ in delivering the right ads at the right time, HCPs started to receive a flood of ineffective advertisements, further burdening HCPs and complicating their already demanding work schedules.

    To solve this concern, Doceree introduced its ‘AI-powered smart nudges’ which allowed only relevant ads to be delivered to HCPs in real-time during critical points of care, allowing them to make informed decisions within the limited time available. This allowed HCPs’ engagement to become more targeted and quality-driven, empowering both – HCPs in their care delivery and pharma marketers in achieving better script lift outcomes beyond campaign impressions.

    Predictive AI in Healthcare: Applications, Benefits, and Challenges
    Explore how predictive AI is transforming healthcare with applications in disease prevention, personalized treatment planning, and resource management.
    StartupTalkySubham Kumar

    StartupTalky: How does Doceree’s data-driven approach to healthcare marketing differentiate it from traditional marketing methods?

    Dr. Jain: While programmatic advertising isn’t new to healthcare and has been leveraged by brands across sectors for many years, the healthcare industry needed to realize how the lack of relevance and effective messaging led to only half of its true potential, contributing to no tangible healthcare outcomes.

    Understanding the cause behind this gap, I attempted to reshape it into an extraordinary framework by integrating real-time context relevance to improve patient outcomes—a solution that went unnoticed at the time. By making the best use of HCP data and clinical data with our HIPAA-certified and patented technology, our data-driven approach to healthcare marketing clearly suggests how technology can create the biggest healthcare impact – if employed wisely.

    Doceree takes a responsible approach by utilizing patient data only at critical moments of care, eliminating the risk of misuse. This precise and conscientious use of HCP and patient data enables us to nudge HCPs toward informed decision-making and enhance HCP-patient engagement.

    What sets us apart is our commitment to delivering meaningful context for impactful outcomes, all while maintaining strict data compliance. Furthermore, as the world’s first and only ‘HCP-only data’ marketplace, we have a reputation for the extensive focus on data safety and integrity.

    StartupTalky: What role does collaboration with pharmaceutical brands play in Doceree’s growth, and how do you maintain strong relationships with them?

    Dr. Jain: We currently collaborate with over 600 pharmaceutical brands worldwide, including the top eight global players, who have been pivotal to Doceree’s growth. What began in 2020 as a modest three-member team has now grown into a thriving organization with over 200 talented professionals spanning Asia, America, and Europe.

    As an entrepreneur and marketer, my vision is straightforward: focus on adding value to your customers’ growth with purpose, and profits will naturally follow. Through our highly precise and real-time context-relevant messaging, our clients save significantly, leveraging solutions like Doceree Insights to optimize campaign performance. This allows them to reinvest those savings into more strategic campaigns. This approach not only enhances value for our clients but also plays a critical role in retaining and renewing partnerships with brands across the globe.

    List of Top 20 Pharmaceutical Companies in India
    Discover top pharmaceutical companies in India that are making a big impact on global healthcare industry by offering best healthcare solutions.
    StartupTalkyAshwini

    StartupTalky: With Doceree expanding globally, what future innovations or products are you most excited about?

    Dr. Jain: There’s much more in store for the global healthcare advertising industry and the broader healthcare business ecosystem from Doceree. As we recently entered Australia in association with WARD 6 and are looking to secure more global partnerships and mergers to offer our clients solutions that are high on innovation with safer and smarter integration of AI. Overall, we plan to add 5 cutting-edge solutions to our offerings in 2025, that will give new heights to an efficient healthcare marketing ecosystem.

    Further, with the core purpose of elevating HCP-patient conversations Doceree will continue to deliver innovative pharmaceutical marketing solutions, while also exploring opportunities for broader business collaboration and growth. Perhaps something transformative is on the horizon– stay tuned! 

    StartupTalky: On International Men’s Day, how do you maintain work-life balance, and what advice would you give to men in demanding roles to protect their mental health?

    Dr. Jain: Working across three time zones, I’ve come to realize that maintaining work-life balance in today’s fast-paced world is no easy feat. Yet, setting boundaries and prioritizing time for yourself and your loved ones is vital for recharging and staying productive. Whether it’s regular exercise, mindful breaks, or occasionally unplugging from work, find what helps you feel your best.

    This International Men’s Day, I urge everyone to challenge the stereotype that men must always appear strong, embrace open conversations about mental health, seek support when needed, and remember that self-care is as crucial as professional success.

    India’s Health-Tech Market to Reach $25 Billion by 2025
    India’s health-tech industry is on an upward trajectory, projected to reach $25 billion by 2025. This rapid growth signals immense opportunities and innovation in healthcare technology within the country.
    StartupTalkySayantan Mondal

  • Khushboo Jain of CarePal Discusses How the Company is Revolutionising Affordable Healthcare Financing

    In this exclusive interaction with StartupTalky, Khushboo Jain, Co-Founder and COO of CarePal Group, shares her journey of transforming healthcare financing in India. She discusses the inspiration behind CarePal, its unique ecosystem of crowdfunding, insurance, and lending, and how technology is improving healthcare access. Jain also talks about her shift from fashion marketing to healthcare, the challenges of being a woman entrepreneur, and offers advice for others. Discover how CarePal is breaking barriers to ensure that quality healthcare is accessible and affordable for millions across India.

    StartupTalky: What inspired you to start CarePal, and how has your vision for healthcare financing in India grown over the years?

    Ms. Jain: The vision behind CarePal Group is rooted in ensuring that no one suffers or faces financial ruin due to unaffordable healthcare. Recognizing the dire impact of medical expenses in India, where millions are pushed into poverty annually, we set out to create a transformative solution. CarePal Group integrates medical crowdfunding, health insurance and benefits, and a lending marketplace to establish a comprehensive healthcare financing ecosystem.

    This innovative approach caters to varied needs, from high-cost treatments to smaller medical expenses, ensuring quality healthcare is accessible to all. Guided by a commitment to community impact, we have surmounted numerous challenges through persistence and creativity. Our mission is to save one million lives in the next decade by revolutionizing healthcare financing in India.

    The mission has evolved to not only alleviate immediate financial burdens but also build long-term solutions for affordable and accessible healthcare, to impact a million lives by 2030.

    Healthcare With Fintech: The Next Decade of Health
    Explore how healthcare with fintech is leading access in India, paving the way for a healthier future and contributing to economic growth by 2047.
    StartupTalkyVarun Bhardwaj

    StartupTalky: ImpactGuru.com has helped thousands of patients raise funds. What unique strategies have made this possible, especially in connecting patients with supporters?

    Ms. Jain: Medical crowdfunding serves as a lifeline for middle and lower-middle-class families facing financial barriers to healthcare. Through focused marketing initiatives, we have extended this support to underserved and impoverished communities, enabling rapid fundraising for critical medical needs. Our ongoing efforts center on enhancing the platform’s features and reach, ensuring every beneficiary receives optimal assistance and an improved experience.

    StartupTalky: CarePal offers multiple services, from crowdfunding to health insurance and lending. How do you make sure each service meets its purpose and also fits into the bigger mission?

    Ms. Jain: At CarePal, we ensure that each service—crowdfunding, health insurance, and healthcare lending—not only fulfills its specific purpose but also aligns with our broader mission of making healthcare affordable and accessible. Each service is designed to address distinct challenges: crowdfunding for urgent medical emergencies, insurance for preventive financial coverage, and lending to bridge funding gaps for uncovered treatments including for critical illnesses like cancer. These offerings are integrated into a cohesive ecosystem, enabling us to deliver tailored solutions based on individual needs.

    By leveraging data-driven insights and maintaining a customer-centric approach, we continuously refine our services to meet user expectations. All our initiatives are guided by our mission to ensure no one suffers due to lack of funds for healthcare, making every effort meaningful and impactful in transforming India’s healthcare financing landscape.

    StartupTalky: How do you see technology like data and AI shaping the future of healthcare financing, and what steps is CarePal taking in this direction?

    Ms. Jain: Data and AI are set to revolutionize healthcare financing by enabling more personalized, efficient, and accessible solutions. AI can analyze vast amounts of medical and financial data to predict costs, assess risks, and tailor financing options to individual needs. It will also play a key role in driving our storytelling narrative, which is a critical component of medical crowdfunding. At CarePal, by staying at the forefront of technological innovation, we aim to build smarter, more scalable solutions that align with our mission to make healthcare accessible to all.

    Revolutionizing Patient Communication and Engagement with AI in Healthcare
    Explore how AI-powered tools are reshaping patient-provider interactions, enhancing adherence to treatment plans, and revolutionizing healthcare delivery.
    StartupTalkySubham Kumar

    StartupTalky: You moved from fashion marketing to healthcare. How did you make this change, and what skills and lessons from your early career help you today?

    Ms. Jain: Transitioning from fashion marketing to healthcare was both challenging and rewarding. The shift required me to adapt quickly to a new industry with different dynamics, but many skills from my early career proved invaluable. In fashion marketing, I honed my abilities in storytelling, branding, and audience engagement—skills that are equally critical in healthcare crowdfunding, particularly in connecting with donors and patients on an emotional level.

    Additionally, my experience in fast-paced, consumer-driven environments helped me develop agility and a focus on customer-centric solutions. These qualities now enable me to design innovative strategies that resonate with diverse audiences in the healthcare financing sector. The lessons of resilience, creativity, and adaptability have been essential in navigating the complexities of healthcare financing and driving impactful initiatives at CarePal.

    StartupTalky: As a woman entrepreneur in healthcare and finance, what challenges have you faced, and how did you turn them into opportunities?

    Ms. Jain: In the early days of CarePal Group, we encountered several significant challenges. Attracting top-tier talent, gaining the trust of investors, connecting with patients in need, and effectively targeting donors were all formidable obstacles. However, our unwavering commitment to our mission and focus on innovation enabled us to overcome these hurdles. This perseverance has been instrumental in driving meaningful progress in healthcare financing, making quality care accessible to more people.

    StartupTalky: What advice would you give to other women who want to make a difference through their business?

    Ms. Jain: As a woman entrepreneur, my advice would be to stay resilient and adaptable. There will always be challenges, but trust in your instincts and don’t be afraid to take bold risks. Seek out mentors and build a strong support network—having people around you who believe in your vision can make all the difference. 

    It’s also important to stay true to your goals while being flexible enough to pivot when necessary. Balance your personal aspirations with your business ambitions, and remember that your unique perspective as a woman is a powerful tool for innovation. Use it to create solutions that are inclusive and forward-thinking. Most importantly, never underestimate your ability to lead and create change. You have the power to pave the way for other women in business and make a lasting impact.

    India’s Health-Tech Market to Reach $25 Billion by 2025
    India’s health-tech industry is on an upward trajectory, projected to reach $25 billion by 2025. This rapid growth signals immense opportunities and innovation in healthcare technology within the country.
    StartupTalkySayantan Mondal

  • Molbio Diagnostics: Shaping the Future of Healthcare

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations.

    Imagine having cutting-edge PCR technology right where it’s needed most—whether in a bustling clinic, a remote village, or even out in the field. Molbio Diagnostics’ Truelab Real-Time Quantitative Micro PCR system makes that possible. It’s not just a lab tool anymore; it’s molecular diagnostics brought directly to the frontline of healthcare. What makes it even more revolutionary? The system works independently of traditional infrastructure, offering a complete solution for disease diagnosis. With its wireless data transfer capabilities, it’s perfect for locations with minimal resources, bringing top-tier diagnostics to places that need it most. This is a game-changer in the global fight against infectious diseases.

    Here’s learning about Molbio Diagnostics, its Founders, Startup Story, Business Model, Revenue Model, Funding, Acquisitions, Growth Competitors, and more.

    Molbio Diagnostics – Company Highlights 

    Company Name Molbio Diagnostics
    Headquarters Verna, Goa
    Sector Medical Equipment Manufacturer
    Founder Sriram Natarajan
    Founded 2000
    Website Molbiodiagnostics.com

    Molbio Diagnostics – About
    Molbio Diagnostics – Industry
    Molbio Diagnostics – Founders and Team
    Molbio Diagnostics – Startup Story
    Molbio Diagnostics – Mission and Vision
    Molbio Diagnostics – Name, Tagline and Logo
    Molbio Diagnostics – Business Model
    Molbio Diagnostics – Revenue Model
    Molbio Diagnostics – Challenges Faced
    Molbio Diagnostics – Funding and Investors
    Molbio Diagnostics – Mergers and Acquisitions
    Molbio Diagnostics – Growth
    Molbio Diagnostics – Awards and Achievements
    Molbio Diagnostics – Competitors
    Molbio Diagnostics – Future Plans

    Molbio Diagnostics – About

    Molecular diagnostics is at the forefront of infectious disease detection, offering unparalleled accuracy by detecting pathogens at the DNA level. Its ability to amplify DNA means it can identify diseases in their earliest stages, thanks to its outstanding sensitivity and specificity. However, until now, this advanced technique has been confined to centralized labs that rely on expensive infrastructure, skilled technicians, and controlled environments. This has created long wait times and logistical hurdles like sample degradation and contamination.

    But Molbio has changed the game. Introducing the Truelab Real-Time Quantitative Micro PCR System—a groundbreaking, portable molecular diagnostics platform designed to work directly at the point of care. This compact, battery-operated system delivers results in under an hour from sample to diagnosis, making same-day reporting and treatment a reality. For emergencies, the system offers real-time data transfer via SMS, email, or data push for instant reporting.

    For doctors and patients, this means a quicker path to a definitive diagnosis, often at the first point of contact, allowing for timely, evidence-based treatment. Early detection not only improves outcomes but also plays a critical role in preventing the spread of disease.

    After rigorous validation, the Indian Council of Medical Research (ICMR) found the Truenat test to be more sensitive and specific than traditional smear microscopy. As a result, it’s now recommended as a frontline diagnostic tool for tuberculosis (TB) and Rifampicin resistance under the RNTCP algorithm. The Ministry of Health has already begun rolling it out across India, with Andhra Pradesh leading the charge by implementing Truenat at the Primary Health Centre level. This innovative approach has significantly boosted TB case detection rates in the state.

    Molbio Diagnostics – Industry

    Diagnostics is poised to play an even more crucial role in patient care in the coming years, especially as molecular diagnostics continues to evolve at a rapid pace, contributing to around 4–5% of the total healthcare expenditure.

    Over the past decade, we’ve seen incredible advancements with the introduction of high-complexity tests and cutting-edge technologies, not just in India, but worldwide where 41% of healthcare spending is on diagnostics.

    Molecular diagnostics has transformed disease detection, offering remarkable accuracy and speed. Today, rapid multiplex PCR assays can identify up to 18 or more viruses simultaneously, significantly boosting diagnostic efficiency and precision.

    Among the many players in India’s molecular diagnostics market, Molbio Diagnostics stands out. This Goa-based company, known for its Truelab Real-Time Quantitative Micro PCR system, has made history by becoming India’s first molecular diagnostics company to surpass a $1 billion valuation. Their innovation is reshaping healthcare, bringing advanced diagnostic capabilities to the forefront of patient care.

    In 2023, the Indian diagnostics market stood at around 13 billion U.S. dollars, with expectations to double by 2028.

    Molbio Diagnostics – Founders and Team

    Sriram Natarajan

    Sriram Natarajan - Founder, Director, and CEO of Molbio Diagnostics
    Sriram Natarajan – Founder, Director, and CEO of Molbio Diagnostics

    Sriram Natarajan is the Founder, Director, and CEO of Molbio Diagnostics Pvt. Ltd. With over three decades of expertise, Mr. Natarajan is the visionary behind Molbio Diagnostics Pvt. Ltd. and the founder of the Tulip Group, India’s largest IVD reagent company. His experience in the diagnostics space spans the development, manufacturing, and marketing of innovative diagnostic devices. With an M.Sc. and M.Phil., he has over four years of academic research experience and an impressive 34 years of expertise in diagnostics. Mr. Natarajan’s career has spanned the development, manufacturing, and marketing of diagnostic devices and kits worldwide, across both private and public sectors. In 1989, he founded the Tulip Group, growing it into India’s largest IVD reagent company and a key player on the global stage, before successfully exiting the company in January 2017.

    Natarajan’s vision for Molbio is to make it a globally impactful company, more closely aligned with societal needs. He also has ambitions to raise capital and transform Molbio into a public limited company, aiming to elevate the company’s credibility and global perception.

    Molbio Diagnostics – Startup Story

    Molbio Diagnostics, founded in 2014, became Goa’s first startup to reach unicorn status, surpassing a turnover of one billion.

    The company has spent over two decades in R&D, led by Sriram Natarajan, collaborating with global healthcare organizations such as CSIR, ICMR, BIRAC, Grand Challenges Canada, BMGF, and FIND. 

    Their work has focused on miniaturizing PCR technology, with patents filed or approved in over 100 countries. In response to the COVID-19 pandemic, Molbio supplied more than 8.2 million testing kits and installed over 4,000 machines in the past year alone, reinforcing their pivotal role in diagnostics.

    While COVID-19 disrupted most industries in FY21, healthcare diagnostics companies found a unique opportunity for growth. Molbio Diagnostics, which played a leading role in India’s COVID-19 screening efforts. Their portable, battery-operated real-time RT PCR point-of-care (PoC) testing system was instrumental in expanding testing capacity across the country. This surge in demand led to a remarkable 25X increase in revenue during FY21.

    Moreover, in March 2022, the Indian government deployed Truenat as a key tool in its door-to-door tuberculosis (TB) screening initiative. Today, over 4,000 Truenat machines are in use across public and private sectors, supporting widespread testing across the country.

    Molbio Diagnostics – Mission and Vision

    Molbio Diagnostics is driven by the mission to improve healthcare by offering precise, fast, and affordable diagnostic solutions. Their goal is to reduce patient suffering, prevent fatalities, and minimize economic loss, ensuring access to top-quality healthcare for all.

    Their vision is to revolutionize healthcare by providing portable, near-care diagnostic tools that make advanced testing accessible anywhere. Known for their WHO-endorsed Truenat real-time PCR platform, Molbio brings critical diagnostic services directly to the patient’s doorstep, enabling rapid, point-of-care testing with their innovative portable devices and kits.

    Molbio Diagnostics Logo
    Molbio Diagnostics Logo

    Molbio Diagnostics’ logo cleverly incorporates molecular and scientific imagery, highlighting their expertise in molecular diagnostics, especially with their flagship product, Truenat. Elements like DNA helixes or molecular patterns point to the company’s commitment to innovative healthcare technology.

    The choice of red in the logo isn’t just for aesthetics—it adds a layer of urgency, perfect for a field like diagnostics where speed and accuracy matter.

    But it’s not all about urgency. Red also taps into emotions, creating a sense of trust, care, and empathy, which are so important in patient care.

    This mix of modern science and thoughtful color choice reflects Molbio’s dedication to delivering cutting-edge and compassionate healthcare solutions.

    Top 9 Revolutionizing Healthcare Analytics Startups in India
    Healthcare industry is blooming in India with the addition of AI in it. Read here to know about the top 9 Healthcare analytic startups in India.
    StartupTalkyPratyusha Srivastava

    Molbio Diagnostics – Business Model

    Molbio Diagnostics operates in the B2B space within the Life Sciences, Infectious Diseases, Sustainability Tech, and Genomics market segments, focusing on providing cutting-edge diagnostic solutions that cater to both public health and sustainability initiatives.

    Molbio Diagnostics – Revenue Model

    Molbio Diagnostics’ flagship product, Truenat, is a real-time IoT-enabled testing kit capable of detecting over 30 diseases. The company also generates substantial revenue from micro PCR workstations, reagent kits, and cartridges. In February 2023, Molbio acquired a majority stake in Prognosys Medical Systems, expanding its portfolio to include digital X-ray machines. Moreover, Molbio is actively developing point-of-care technologies in areas like hematology, cancer, antimicrobial resistance, next-generation sequencing, and syndromic testing.

    Molbio Diagnostics – Challenges Faced

    Overcoming Supply Chain Gaps

    Molbio Diagnostics faces some significant challenges in addressing the global demand for diagnostic supplies, especially when infectious diseases spread rapidly. One of their key priorities is ensuring that their micro PCR analyzers can be manufactured locally, helping them stay ahead of supply shortages. This approach not only speeds up production but also allows them to keep costs down without compromising on the performance of the devices.

    Ensuring Longevity

    Another challenge in the medical device industry is the need for long-term availability of parts, ensuring that products don’t become obsolete too quickly. To tackle this, Molbio has partnered with SMART Wireless Computing, using their Snapdragon-based solutions, which offer extended-life support. This ensures that Molbio’s devices remain functional and supported for years to come, addressing a crucial issue faced by medical product manufacturers globally.

    In FY23, Molbio reported a loss of Rs 3.4 crore, a stark contrast to the profit of Rs 215 crore seen in FY22. The company experienced a significant 57% decline in scale and rising fixed costs have added pressure.

    Despite these challenges, Molbio Diagnostics remains a beacon of innovation and resilience in the healthcare industry. With strategic planning and a commitment to public health, they’re poised to navigate whatever comes next on their journey. 

    Molbio Diagnostics – Funding and Investors

    Molbio received its first funding through the ATC Grant as a government initiative to aid in the effort to tackle COVID in 2022. 

    Date of Funding Funding Amount Round Name Post Money Valuation Investors
    September 23, 2022 $85 million Series C $1.6 billion Temasek, Motilal Oswal
    May 28, 2021 $19.2 million Series B $225 million Motilal Oswal
    January 22, 2020 $19.7 million Unattributed $1.21 billion Motilal Oswal, Shankar Gopalakrishnan

    Molbio Diagnostics has raised a total funding of $124 million over 4 rounds to date. The company’s annual revenue as of Mar 31, 2023 is INR 337 crore ($42 million).

    List of 116 Unicorn Startups in India | Top Unicorns in India
    India has already seen 116 unicorn startups. Here’s an exhaustive list of all unicorn companies in India, including those that joined the unicorn club in 2024.
    StartupTalkyAnik Banerjee

    Molbio Diagnostics – Mergers and Acquisitions

    In February 2023, Molbio Diagnostics acquired a 70% stake in Prognosys Medical Systems, aiming to enhance its presence in digital radiography. This acquisition aligns with their “Universal Access” portfolio, combining the strengths of Molbio’s Truenat systems with Prognosys’ Prorad systems to screen and confirm contagious diseases like tuberculosis, COVID-19, and chest anomalies across large populations.

    Molbio Diagnostics – Growth

    In September 2022, Molbio Diagnostics made headlines as Goa’s first startup to reach unicorn status. This remarkable achievement came after raising around INR 680 crore from notable investors, including Temasek and Motilal Oswal Private Equity (MOPE). What a way to kick off a journey in the healthcare sector!

    But the success didn’t stop there. IN FY21 Molbio’s revenue took a giant leap, skyrocketing to INR 1,272 crore from just INR 51.53 crore in FY20.

    In FY21, the company posted a profit of INR 472.7 crore, a dramatic change from the previous year’s loss of INR 16.27 crore. Molbio is not just surviving but thriving. In August 2023, Molbio Diagnostics teamed up with CrisprBits in a strategic collaboration aimed at integrating CRISPR technology into point-of-care (POC) testing. 

    This partnership marks a significant step toward enhancing diagnostic capabilities. In the fiscal year 2023-24, Molbio reported a turnover of approximately INR 800 crore, reflecting its continued growth and innovation in the healthcare sector. In FY23, Molbio Diagnostics faced significant challenges, reporting a loss of INR 3.4 crore compared to a profit of INR 215 crore in FY22. The company experienced a dramatic 57% decline in scale, and rising fixed costs added further pressure to its operations.

    At the heart of this success is Truenat, Molbio’s flagship product. This real-time IoT-enabled testing kit is a game-changer, capable of detecting over 30 diseases. The Indian government even deployed it as a frontline tool in its door-to-door TB screening initiative—showcasing its crucial role in public health efforts.

    Molbio Diagnostics – Financials 

    Molbio Financials FY22 FY23
    Operating Revenue INR 776 crore INR 332 crore
    Total Expenses INR 486 crore INR 328 crore
    Profit/Loss INR 215 crore INR -3.4 crore
    Molbio Diagnostics Financials FY23
    Molbio Diagnostics Financials FY23

    In FY22, Molbio earned an operating revenue of INR 776 crore and spent INR 486 crore, leading to a profit of INR 215 crore. In FY23, their revenue dropped by 57%, falling to INR 332 crore. At the same time, their expenses decreased slightly by 32%, down to INR 328 crore. However, this resulted in a loss of INR 3.4 crore for FY23.

    Molbio Diagnostics – Awards and Achievements

    Molbio Diagnostics is awarded with the following awards:

    • BW Healthcare World Excellence Award 2022
    • Changemaker Award 2024 – Digital Transformation
    • BioSpectrum Product of the Year Award 2020The TrueNat TB test won the BioSpectrum Product of the Year Award 
    • Ranking on the Burgundy Private Huron India 500 ListThe company proudly secured the 275th position on the Burgundy Private Huron India 500 list.

    With a robust portfolio of awards and recognitions, this innovative company in the healthcare sector’s future looks bright. 

    Molbio Diagnostics – Competitors

    Molbio Diagnostics operates in a competitive landscape in India, with various players vying for market share. 

    One notable competitor is Bigtec Labs, which functions as the research and development (R&D) wing of Molbio Diagnostics. Bigtec Labs has made significant strides in the medical device sector, developing and commercializing innovative products like a portable micro-PCR system, further highlighting the dynamic nature of the diagnostics industry.

    Other competitors of the company are as below:

    • Thalys Medical Technology
    • Demka Sakti
    • Grupo SIM
    • Spectrum Medical

    Molbio Diagnostics – Future Plans

    The company has set its sights on launching an initial public offering (IPO) in FY25, aiming for a target valuation between INR 22,000 crore and INR 24,000 crore. Exciting times ahead!

    Molbio isn’t resting on its laurels. The company is committed to strengthening its diagnostic testing capabilities, developing innovative point-of-care technologies, and expanding its reach in the global market.

    FAQs

    What does Molbio Diagnostics do?

    Molbio Diagnostics’ Truelab Real-Time Quantitative Micro PCR System—a groundbreaking, portable molecular diagnostics platform designed to work directly at the point of care. This compact, battery-operated system delivers results in under an hour from sample to diagnosis, making same-day reporting and treatment a reality.

    Is Molbio Diagnostics a Unicorn?

    Founded in 2014, Molbio Diagnostics became Goa’s first startup to surpass a turnover of one billion, achieving Unicorn status.

    Who is the founder of Molbio Diagnostics?

    Sriram Natarajan is the Founder, Director, and CEO of Molbio Diagnostics Pvt. Ltd.

  • Tanya Goodwin of Botanical Chemist Palm Cove on Revolutionizing Healthcare with Sustainable and Personalized Solutions

    In this exclusive interview with StartupTalky, we speak with Tanya Goodwin, the visionary Founder and CEO of Botanical Chemist Palm Cove. Tanya shares her diverse and rewarding professional journey, from hospital and community pharmacy to a Fortune 500 pharmaceutical company, culminating in the establishment of Botanical Chemist Palm Cove.

    Driven by a passion for sustainable and personalized healthcare, Tanya discusses her innovative approach, leadership style, and the core offerings of her company. She also talks about the challenges faced and shares the future direction of her organization in revolutionizing global healthcare.

    StartupTalky: Could you share insights into your professional journey and experiences? Additionally, what drives and motivates your daily routines?

    Ms. Goodwin: My professional journey has been diverse and rewarding, encompassing roles in hospital, community, and corporate pharmacy settings. Starting as a hospital pharmacist, I gained invaluable experience in patient care and medication management. Transitioning to community pharmacy, I learned the importance of personalized healthcare and building strong patient relationships. My time with a Fortune 500 pharmaceutical company broadened my understanding of the industry and honed my strategic thinking.

    Establishing Botanical Chemist Palm Cove was a culmination of these experiences, driven by a passion for sustainable and personalized healthcare. Every day, I am motivated by the desire to make a positive impact on my patients’ lives and contribute to the health and well-being of our community. The innovative use of technology in healthcare, coupled with our commitment to sustainability, fuels my drive to push boundaries and find better solutions.

    My daily routines are driven by a commitment to continuous learning, embracing new challenges, and fostering a supportive and collaborative team environment. Seeing the difference our work makes in the lives of our patients is incredibly rewarding and serves as a constant source of motivation and inspiration.

    StartupTalky: Reflecting on your extensive industry background, what standout lessons have you gained, and can you elaborate on your distinctive leadership style?

    Ms. Goodwin: Reflecting on my extensive industry background, several standout lessons have emerged. Firstly, adaptability is crucial. The healthcare industry is constantly evolving, and being able to pivot and innovate in response to changes has been vital. Secondly, the importance of empathy and patient-centered care cannot be overstated. Understanding and addressing the unique needs of each patient fosters trust and improves outcomes. Lastly, continuous learning and professional development are key to staying ahead in this dynamic field.

    My leadership style is collaborative and inclusive. I believe in empowering my team by fostering an environment where everyone feels valued and heard. Encouraging open communication and diverse perspectives leads to more innovative solutions and a stronger, more cohesive team. Additionally, I prioritize ethical practices and integrity, always striving to lead by example.

    I also emphasize the importance of work-life balance, understanding that a motivated and well-balanced team performs at its best. By combining these elements, I aim to create a supportive and dynamic workplace where both employees and patients can thrive, driving our mission of delivering exceptional, personalized, and sustainable healthcare.

    StartupTalky: Dive into the core offerings of Botanical Chemist Palm Cove. Furthermore, shed light on the unique value propositions that individuals or businesses can anticipate from your solutions.

    Ms. Goodwin: Botanical Chemist Palm Cove offers a comprehensive range of healthcare solutions, including personalized medicine, compounding services, and the latest medical equipment. We specialize in customized treatments for skincare, anti-aging, nutraceuticals, hormones, pain management, and veterinary needs. Our core offerings also include innovative pharmaceutical products and expert healthcare advice tailored to individual patient needs.

    What sets us apart is our commitment to sustainability and holistic care. We use advanced technology and sustainable practices to create effective, safe, and environmentally conscious healthcare solutions. Our team of skilled professionals ensures that each product and service is tailored to meet the unique needs of our clients, offering unparalleled personalization.

    Additionally, we are dedicated to serving under-served communities, having provided after-hours delivery of medicines and medical equipment to palliative care patients, Aboriginal and Torres Strait Islander families, the elderly, and LGBTQIA+ members. Our participation in the Australian Government’s Closing the Gap scheme further highlights our commitment to equitable healthcare. Clients can expect innovative, personalized, and compassionate care that truly makes a difference.

    Machine Learning in Healthcare Industry
    Machine Leaning has become the new future in this world. Find out how it is bringing change in the healthcare industry.
    StartupTalkyArbaz Sayed

    StartupTalky: In navigating your role as a leader, what significant business challenges have you confronted, and what strategies did you employ to successfully overcome them?

    Ms. Goodwin: Navigating my role as a leader at Botanical Chemist Palm Cove has presented several significant challenges, particularly during the COVID-19 pandemic. The sudden need for rapid adaptation in supply chain logistics, ensuring the safety of our team, and maintaining uninterrupted service to our patients were primary concerns. To address these, I implemented robust contingency plans, diversified our supply sources, and leveraged digital platforms to facilitate remote work and telehealth services.

    Another challenge has been staying ahead in the competitive field of sustainable medicine. This required continuous investment in research and development, as well as staying up to date with advanced technologies like AI and IoT to enhance our offerings. Collaborating with industry experts and fostering a culture of innovation within the team has been crucial.

    Overall, these strategies—embracing technology, fostering innovation, diversifying supply chains, and community-focused initiatives—have been key to overcoming business challenges and driving our success.

    StartupTalky: Balancing the preservation of company heritage with the imperative to innovate and adapt to change can be challenging. How do you manage this delicate equilibrium within your organization?

    Ms. Goodwin: Balancing the preservation of company heritage with the need to innovate is indeed a delicate task. At Botanical Chemist Palm Cove, we manage this equilibrium by adhering to our core values while embracing cutting-edge advancements. Our heritage is built on a foundation of personalized, compassionate healthcare and a commitment to sustainability. We honour these principles by ensuring they remain central to all our operations and decisions.

    To foster innovation, we continuously invest in research and development, exploring new technologies like AI and IoT to enhance our healthcare solutions. This approach allows us to offer modern, effective treatments while maintaining our traditional emphasis on personalized care. We also actively seek feedback from our clients and employees, using these insights to drive improvements and stay aligned with contemporary needs.

    Moreover, we promote a culture of continuous learning and adaptability within our team, encouraging them to embrace new ideas and methods without losing sight of our core mission. This strategy enables us to evolve and grow while staying true to the values that define our heritage. By integrating innovation with our foundational principles, we ensure our company remains both forward-thinking and deeply rooted in its original ethos.

    StartupTalky: Envisioning the future, could you elaborate on the destination you are steering towards in your professional journey?

    Ms. Goodwin: Envisioning the future, my professional journey is focused on steering Botanical Chemist Palm Cove towards becoming a global leader in sustainable medicine. We aim to revolutionize healthcare by integrating advanced technologies like AI and IoT to develop innovative, personalized treatments that meet the evolving needs of our patients. Our goal is to expand our reach internationally, providing top-notch healthcare solutions to underserved communities worldwide.

    In the next few years, we plan to launch a new range of sustainable healthcare products, further our research and development efforts, and establish strategic partnerships with global health organizations. We are committed to continuous learning and adaptation, ensuring our offerings remain at the forefront of medical advancements.

    Moreover, I am dedicated to fostering a culture of inclusivity and compassion within our team, empowering our employees to contribute their best work and drive our mission forward. By maintaining our core values of sustainability, quality, and personalized care, we aim to make a significant positive impact on global health, ensuring that our journey is not just about business growth but also about improving lives and making healthcare accessible to all.

    Best Health and Wellness Business Ideas for A Entrepreneurs
    Discover 10 cutting-edge health and wellness business ideas to start a successful venture that empowers people to live healthier, happier lives.
    StartupTalkyRia Sahni

  • Medical Advancements and Challenges in AI Yet How Is It Changing the Industry?

    This article has been contributed by Dr. Sravani Reddy G, Founder & CEO, Soprav Health Consulting.

    AI is fundamentally transforming the healthcare industry by revolutionizing various aspects of patient care, diagnosis, treatment, and administrative processes. Through the utilization of advanced algorithms and machine learning techniques, AI enables healthcare providers to analyze vast amounts of data quickly and accurately, leading to improved clinical decision-making. Additionally, AI-powered technologies enhance efficiency in tasks such as medical imaging interpretation, predictive analytics for disease prevention, personalized treatment planning, and drug discovery. Moreover, AI-driven solutions streamline administrative tasks, optimize workflows, and reduce healthcare costs. Overall, AI is catalyzing a paradigm shift in healthcare, driving innovation, improving patient outcomes, and enhancing the overall quality and accessibility of healthcare services.

    The vast realm of artificial intelligence (AI) is rapidly evolving, pushing boundaries, and revolutionizing healthcare. Recent advancements, including improved access to extensive health data, faster computer processing, a growing pool of AI experts, and accessible AI tools, are seamlessly integrating AI into modern healthcare. Despite initial hesitancy, the healthcare sector is embracing AI to address workforce shortages, meet patient expectations, and leverage technological innovations.

    Managing the Intricacies of Healthcare Data
    Interpretability
    Ensuring Ethical Considerations and Patient Privacy
    Integration with Clinical Workflow
    Cost and Resource Constraints

    However, the healthcare sector has traditionally been slow to embrace such technology and it is essential to acknowledge that we are still in the early stages of this journey, with much ground left to cover. Some of the concerns surrounding involve:

    Managing the Intricacies of Healthcare Data

    While access to patient information has improved, AI integration faces a significant hurdle due to the intricacies and complexities of healthcare data. Unlike sectors with abundant and readily available data, healthcare data is diverse, complex, and fragmented across different systems. This presents unique challenges for AI implementation, requiring innovative strategies for integration, interoperability, and standardization.

    Interpretability

    Many AI models, such as deep learning algorithms, are often considered “black boxes” due to their complex nature, making it challenging for healthcare professionals to understand how they arrive at specific conclusions or recommendations. Improving the interpretability of AI systems is crucial for building trust and acceptance among clinicians.

    Ensuring Ethical Considerations and Patient Privacy

    In the healthcare sector, where decisions directly impact patient lives, ensuring ethical considerations and patient privacy is paramount. AI technologies must adhere to rigorous ethical standards and regulatory guidelines to safeguard patient data and maintain trust in healthcare systems. Transparency, accountability, and patient-centric approaches are essential to responsible AI integration.

    Total Data Storage Capacity Compared To The Total Amount Of Healthcare Data
    Total Data Storage Capacity Compared To The Total Amount Of Healthcare Data

    Integration with Clinical Workflow

    While some healthcare sub-sectors have experts familiar with basic AI tools, but many medical practitioners still face workflow issues. Integrating AI seamlessly into existing clinical workflows and EHR systems remains a challenge. Healthcare professionals require user-friendly interfaces and interoperable AI solutions that enhance existing practices without disrupting patient care or workflow efficiency.

    Cost and Resource Constraints

    Developing and implementing AI technologies in healthcare can be costly and resource-intensive, particularly for smaller healthcare facilities or resource-limited settings. Addressing cost barriers and providing adequate training and support for healthcare professionals to use AI tools effectively is essential for ensuring equitable access and adoption across different healthcare settings.

    Although challenges such as data complexity and regulatory obstacles persist, the adoption of AI in healthcare is steadily increasing. As the world becomes more interconnected, particularly through avenues like medical tourism, AI and ML present considerable opportunities to enhance the healthcare journey. It’s widely acknowledged that AI holds the potential to revolutionize patient care, emphasizing precision medicine and personalized services. Moving forward, it’s imperative that the advancement of AI in healthcare remains grounded in a commitment to innovation and empathy, ultimately striving to enhance outcomes and elevate the quality of life for individuals globally.

    How AI, Big Data, and IoT Revolutionise Personalised Diet Plans in Healthcare
    Explore the transformative impact of personalized diet plans driven by advancements in technology like AI, wearables, and smartphone solutions.
    StartupTalkySubham Agrawal